These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38171188)

  • 21. Overview of receptor allosterism.
    Gregory KJ; Sexton PM; Christopoulos A
    Curr Protoc Pharmacol; 2010 Dec; Chapter 1():Unit 1.21. PubMed ID: 21935895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Protein Allosteric Signalling Pathways and Functional Residues Through Paths of Optimised Propensity.
    Wu N; Yaliraki SN; Barahona M
    J Mol Biol; 2022 Sep; 434(17):167749. PubMed ID: 35841931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence-dependent model of allosteric communication.
    Guarnera E; Berezovsky IN
    J Chem Phys; 2023 Apr; 158(13):135101. PubMed ID: 37031128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and structural perspectives on allosteric modulation of GPCRs.
    Langmead CJ; Christopoulos A
    Curr Opin Cell Biol; 2014 Apr; 27():94-101. PubMed ID: 24680434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-talk between allosteric and orthosteric binding sites of γ-amino butyric acid type A receptors (GABA
    Payghan PV; Nath Roy S; Bhattacharyya D; Ghoshal N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3065-3080. PubMed ID: 30608219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unified view of "how allostery works".
    Tsai CJ; Nussinov R
    PLoS Comput Biol; 2014 Feb; 10(2):e1003394. PubMed ID: 24516370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D; Christopoulos A; Sexton PM
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.
    Lu S; He X; Ni D; Zhang J
    J Med Chem; 2019 Jul; 62(14):6405-6421. PubMed ID: 30817889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in NMR Methods to Identify Allosteric Sites and Allosteric Ligands.
    Abdelkarim H; Hitchinson B; Banerjee A; Gaponenko V
    Adv Exp Med Biol; 2019; 1163():171-186. PubMed ID: 31707704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design of dualsteric GPCR ligands: quests and promise.
    Mohr K; Tränkle C; Kostenis E; Barocelli E; De Amici M; Holzgrabe U
    Br J Pharmacol; 2010 Mar; 159(5):997-1008. PubMed ID: 20136835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting protein flexibility to predict the location of allosteric sites.
    Panjkovich A; Daura X
    BMC Bioinformatics; 2012 Oct; 13():273. PubMed ID: 23095452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance.
    Ni D; Li Y; Qiu Y; Pu J; Lu S; Zhang J
    Trends Pharmacol Sci; 2020 May; 41(5):336-348. PubMed ID: 32171554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs.
    Platania CBM; Bucolo C
    Methods Mol Biol; 2021; 2253():245-254. PubMed ID: 33315227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
    Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
    Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.
    Gregory KJ; Hall NE; Tobin AB; Sexton PM; Christopoulos A
    J Biol Chem; 2010 Mar; 285(10):7459-74. PubMed ID: 20051519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The different ways through which specificity works in orthosteric and allosteric drugs.
    Nussinov R; Tsai CJ
    Curr Pharm Des; 2012; 18(9):1311-6. PubMed ID: 22316155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research progress of indole-fused derivatives as allosteric modulators: Opportunities for drug development.
    Luo ML; Zhao Q; He XH; Xie X; Zhu HP; You FM; Peng C; Zhan G; Huang W
    Biomed Pharmacother; 2023 Jun; 162():114574. PubMed ID: 36996677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.